SCHEMBL30973552

SCHEMBL30973552

CC1(C)OB(c2ccc3c(c2OC(F)F)CCO3)OC1(C)C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25417561 0.79 LPL (0.33)
SCHEMBL30973447 0.79 HTR2C (0.31)
SCHEMBL31394265 0.78 LPL (0.35) MAPK1
SCHEMBL31394467 0.76 MAPK1 (0.35) MAPK1
SCHEMBL12533487 0.76 MAPK1 (0.35) MAPK1
SCHEMBL10157280 0.76 P2RX7 (0.33) MAPK1
SCHEMBL30413931 0.76 MAOB (0.40)
SCHEMBL25417565 0.76 MAOB (0.40)
SCHEMBL15132885 0.75 MAPK1 (0.34) MAPK1
SCHEMBL25419802 0.75 MAPK1 (0.34) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 EP disclosed
WO-2024145623-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2024-07-04 WO disclosed